CN1680412A - Transition metal complex, synthesis and use thereof - Google Patents

Transition metal complex, synthesis and use thereof Download PDF

Info

Publication number
CN1680412A
CN1680412A CN 200510023632 CN200510023632A CN1680412A CN 1680412 A CN1680412 A CN 1680412A CN 200510023632 CN200510023632 CN 200510023632 CN 200510023632 A CN200510023632 A CN 200510023632A CN 1680412 A CN1680412 A CN 1680412A
Authority
CN
China
Prior art keywords
autoclave
ligand
hydrogen
cdcl
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510023632
Other languages
Chinese (zh)
Other versions
CN1331874C (en
Inventor
丁奎岭
荆庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CNB2005100236320A priority Critical patent/CN1331874C/en
Publication of CN1680412A publication Critical patent/CN1680412A/en
Application granted granted Critical
Publication of CN1331874C publication Critical patent/CN1331874C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

A transient metal complex, its synthetic method and use are disclosed. It can be used for catalyst asymmetric hydrogenation reaction of acetophenone and its derivative, benzophenone and its derivative, methyl cyclopropyl-methyl ketone, gamma -N, N-dimethy- alpha-benzol-acetone and its derivative and other ketone compound. It achieves simple synthesis and industrial production.

Description

Transition metal complex, preparation method and use
Technical field
The present invention relates to a class transition metal complex, preparation method and use.These metal complexs of synthetic can be used for the reaction of catalysis asymmetric catalytic hydrogenation.This class complex compound can the catalysis methyl phenyl ketone and derivative, benzophenone and derivative thereof, methyl cyclopropyl ketone, γ-N, the asymmetric catalytic hydrogenation reaction of N-dimethylamino-α-Propiophenone and derivative thereof and other ketone compounds.
Background technology
The asymmetric catalytic hydrogenation reaction is focus [Ohkuma, the T. in the current asymmetric synthesis field; Kitamura, M.; Noryori, R. (1999) Asymmetric Hydrogenation.In:Ojiama, I. (ed) CatalyticAsymmetric Synthesis. (2nd Ed.) .Wily-VCH:New York (Englinsh) 2000].Asymmetric catalytic hydrogenation is constantly developed to advancing most several years from the appearance of Wilkinson catalyzer in 1956.The asymmetric hydrogenation of ketone compounds has also had development [Bakos, J.T. rapidly in recent two decades; Heil, B.L.J.Organomet.Chem.1985,279,23], [Jiang, Q.; Jiang, Y.; Xiao, D.; Zhang, X.Angew.Chem.Int.Ed Engl.1998,37,1100].A breakthrough progress is that Noyori group realizes that they find at complex compound [RuCl 2(S)-BINAP] in, add two amine ligands, can generate a kind of structure is tans-[RuCl 2(phosphane) (1,2-diamine)] complex compound, in the presence of alkali (as t-BuOK or KOH), the asymmetric hydrogenation of catalyzing ketone substrate [Noyori, R. efficiently; Takeshi, O.; Hirohito, O.Shohei, H.; Takao, I.J.Am.Chem.Soc.1995,117,2675], [Noyori, R.; Ohkuma, T.; Douce, H.; Murata, K.; Yokozawa, T.; Kozawa, M.; Katayama, E.; England, A.F.; Ikariya, T., Angew.Chem.Int.Ed.1998,37,1703].In recent years, emerged many chiral diphosphine ligands again, be applied in the asymmetric hydrogenation of ketone compounds, also can obtain extraordinary result [Jing, W.; Hua, C.; Waihim, K.; Rongwei, G.; Zhongyuan, Z.; Chihung, Y.; Chan, S.C., J.Chem.Soc.2002,67,7908], [Jing, W.; Jian, X.; Rongwei, G.; Chihung, Y.; Chan, S.C., Chem.Eur.J.2003,9,2963], [Jian, H.X.; Xin, L.W.; Fu, Y.; Shuo, F.Z.; Bao, M.F.; Hai, F.D.; Zhou, Q.L.J.Am.Chem.Soc.2003.125,4404], [Mark, J.; William, H.; Daniela, H.; Christophe, M.; Antonio, Z.G.Org.Lett.2000,26,4173].And recently Mikami group cooperate with Noyori group, will the activatory application of policies not arrived [Okuma, T. in the middle of the asymmetric hydrogenation of ketone substrate; Doucet, H.; Pham, T.; Mikami, K.; Korenaga, T.; Terada, M.; Noyori, R.J.Am.Chem.Soc., 1998,120,1086], [Mikami, K.; Korenaga, T.; Terada, M.; Ohkuma, T.; Pham, T.; Noyori, R.Angew.Chem.Int.Ed.Ehgl., 1999,38,495], also obtained result preferably.Relevant have research [Katayama, E. are also arranged utilizing aspect achiral phosphine part; Inoue, T.JP2001002610,2001], [Ooka, H.; Kanagawa, Inoue, T.WO 007506 A1,2004], [Suparabhom, S.; Susanne, L.; Chen, W.P.; Xiao J.L.J.Mole.Catal.A, Chemical 2003,196,125-129].
However, the synthetic difficulty that still compares of the chiral diphosphine ligand that these synthetic these catalyzer are used or the part of racemization, therefore, patent of the present invention will be an object with the asymmetric catalytic hydrogenation reaction, practical catalyst system inexpensive to develop, efficient, highly selective is a target, by new ideas and the combinational chemistry that uses above-mentioned asymmetric activation, develop not only practicality but also asymmetric catalytic hydrogenation system efficiently.
Summary of the invention
The purpose of this invention is to provide a kind of transition metal complex.Such metal complex can be used for the asymmetric catalytic hydrogenation reaction.Especially metal Ru complex compound.
Another object of the present invention provides the synthetic method of above-mentioned transition metal complex.
Purpose of the present invention also provides the application with above-mentioned complex compound.Can be used for the catalysis asymmetric hydrogenation, further describe to being applied to methyl phenyl ketone and derivative thereof, benzophenone and derivative thereof, methyl cyclopropyl ketone, γ-N, the catalytic hydrogenation of N-dimethylamino-α-Propiophenone and derivative thereof and other ketone compounds.
The overall texture formula of the transition metal complex that this patent is related is as follows: Wherein A or B can be R 1R 2R 3P -, perhaps A and B are D or E=R 7Or R 8, perhaps D and E=R 13Above-mentioned transition metal complex can be the metal complex of metal complex, biphosphine ligand and monoamine part of metal complex, monophosphorus ligand and the diamine ligand of monophosphorus ligand and monoamine part or the metal complex of biphosphine ligand and diamine ligand.Structural formula also further can be described below:
Figure A20051002363200071
C1 C2
Figure A20051002363200073
Or
C3 C4
In all structural formulas, M can be transition metal such as Ru, Pd, Cu or Fe, and X can be chlorine, bromine, iodine.R 9Can be hydrogen, methyl sulphonyl, to Methyl benzenesulfonyl base etc.
R in structural formula C1 1, R 2, R 3, R 4, R 5Or R 6Can be C 2-12Alkyl, described alkyl can be ethyl, n-propyl, sec.-propyl, cyclopropyl, normal-butyl, the tertiary butyl, cyclopentyl, cyclohexyl, suberyl, phenyl, benzyl, 3,5-dimethyl benzyl, 1-naphthyl, 2-naphthyl and Deng.R 14Or R 15Can distinguish hydrogen, methyl, ethyl, n-propyl, sec.-propyl, cyclopropyl, normal-butyl, the tertiary butyl, cyclopentyl, cyclohexyl, suberyl, methoxyl group, oxyethyl group, positive propoxy, isopropoxy, phenyl, phenoxy group, methylphenoxy, 3,5-3,5-dimethylphenyl, benzyl, 3,5-dimethyl benzyl and naphthyl etc.
When adopting chirality monoamine part, R 7Or R 8Can for R 17Can be methyl, ethyl, n-propyl, sec.-propyl, methoxyl group, oxyethyl group, positive propoxy, isopropoxy etc.The absolute configuration of chirality monoamine part both can be the R configuration, also can be the S configuration.
When adopting the chirality diamine ligand, catalyst structure can be expressed as C3 and C4, wherein R respectively 13Can be the following group:
Figure A20051002363200077
And R wherein 18Or R 19Can be respectively hydrogen, methyl, ethyl, n-propyl, sec.-propyl, methoxyl group, oxyethyl group, positive propoxy, isopropoxy, etc.The absolute configuration of chirality diamine ligand both can be (R, R)
Figure A20051002363200081
Or
Configuration also can be (S, S) configuration.
When adopting biphosphine ligand, catalyst structure can further be expressed as C2 and C3, wherein R 12Can be the following group:
Figure A20051002363200084
Or
And R wherein 10Or R 11Can be respectively phenyl, p-methylphenyl, 3,5-3,5-dimethylphenyl etc.
The preparation of such complex compound can be under 0 ℃-100 ℃ in organic solvent neutralization reaction temperature, obtained in 0.5～20 hour by transistion metal compound, diamine ligand or monoamine part, biphosphine ligand or monophosphorus ligand reaction, wherein the mol ratio of transistion metal compound, diamine ligand or monoamine part, biphosphine ligand or monophosphorus ligand is 1: 1～5: 1～5, wherein the structural formula of diamine ligand or monoamine part is A and B, and the structural formula of biphosphine ligand or monophosphorus ligand is
Figure A20051002363200086
With Wherein A, B, E, D and R 9As previously mentioned.When adopting monoamine or monophosphorus ligand, the mol ratio of transistion metal compound and monoamine or monophosphorus ligand is 1: 3～5, recommends 1: 4; When adopting diamine or biphosphine ligand, the mol ratio of transistion metal compound and diamine or biphosphine ligand is 1: 1～3, recommends 1: 2.Described transistion metal compound is the halogenide of Ru, Pd, Cu or Fe or their complex compound, as [RuX 2(C 6H 6)] 2, RuX 3, PdX 2, CuX 2, FeX 2Deng.
Specifically being represented by following reaction formula, is example with the metal Ru complex compound:
Figure A20051002363200088
Figure A20051002363200092
Figure A20051002363200094
Perhaps
R in the reaction formula 1-R 13Group described as defined above.
The organic solvent that uses in aforesaid method of the present invention can be benzene,toluene,xylene, trimethylbenzene, acetonitrile, ether, tetrahydrofuran (THF), glycol dimethyl ether, trichloromethane, methylene dichloride, methyl alcohol, ethanol, Virahol, N, dinethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide (DMSO), N-Methyl pyrrolidone etc.
The absolute configuration of the chirality monoamine part that the present invention is used both can be (R) configuration, also can be (S) configuration.The absolute configuration of chirality diamine ligand both can be that (R, R) configuration also can be (S, S) configuration.
The synthetic method of transition metal complex of the present invention is not only easy, be fit to suitability for industrialized production, and can be used for the catalysis asymmetric hydrogenation, be applied to methyl phenyl ketone and derivative thereof, benzophenone and derivative thereof, methyl cyclopropyl ketone, γ-N furtherly, the catalytic hydrogenation of N-dimethylamino-α-Propiophenone and derivative thereof and other ketone compounds.
Specific implementation method
Help further to understand the present invention by following embodiment, but do not limit the content of invention.
Preparation of catalysts
Preparation method of the present invention can be further as follows with the preparation process embodiment of representational compound:
Method one
[(Ph 3P) 2RuCl 2(R, R)-DPEN be prepared as example]
DPEN is 1, the 2-diphenyl ethylene diamine
Embodiment 1: catalyzer 6 (Ph 3P) 2RuCl 2(R, R)-preparation of DPEN
Figure A20051002363200101
Universal method (method one): under argon shield with 50mg (0.24mmol) RuCl 3With 300mg (1.14mmol) PPh 3Put into reaction tubes, and load onto reflux.Add the anhydrous CH of 12mL 3OH, reflux 5 hours.This moment, the red-brown solid of meeting was separated out, and filtered under argon shield, washed solid with anhydrous diethyl ether, and the decompressing and extracting solvent is directly used in next step reaction.
Under argon shield, the solid 153mg (0.16mmol) of above-mentioned powdery is put into reaction tubes, add the anhydrous CH of 2mL 2Cl 2, stir after 10 minutes, and adding 38.2mg (0.18mmol) (R, R)-1, the 2-diphenyl ethylene diamine, stirring is spent the night.Add the 5mL anhydrous n-hexane, can separate out pale brown look solid, under argon shield, filter, use anhydrous CH 2Cl 2And the anhydrous n-hexane recrystallization can get pale brown look crystal 109mg.Productive rate: 75%.M.p.213-215℃(Dec.)；[α] D 20＝+170.4°(c＝0.45，CHCl 3)；IR(KBr)ν3313cm -1(N-H)； 1H?NMR(300MHz，CDCl 3)：δ7.53(s，12H)，7.24-7.07(m，24H)，6.85(s，4H)，4.29(t，J＝4.5Hz，2H)，3.70(m，2H)，3.36(s，1H)，3.34(s，1H)； 31P?NMR(121MHz，CDCl 3)：δ46.91ppm。
Embodiment 2: catalyzer 7 (Ph 3P) 2RuCl 2(NH 2CH 2CH 2NH 2)
Employing method one, the first step refluxed 10 hours, productive rate: 74%.
1H?NMR(300MHz，CDCl 3)：δ7.52-7.46(m，12H)，7.29-7.24(m，6H)，7.13(t，J＝7.5Hz，12H)，2.99(br，4H)，2.79(s，4H)； 31P?NMR(121MHz，CDCl 3)：δ44.49ppm。
Embodiment 3: catalyzer 8
Employing method one, the first step refluxed 4 hours, productive rate: 71%.
M.p.234-235℃(Dec.)；[α] D 20＝+115.5°(c＝0.54，CHCl 3)；IR(KBr)ν3312cm -1(N-H)； 1H?NMR(300MHz，CDCl 3)：δ7.17(t，J＝9.9Hz，12H)，7.10-7.07(m，5H)，6.95-6.87(m，5H)，6.80(s，4H)，4.30(t，J＝4.8Hz，2H)，3.69-3.66(m，2H)，3.41(s，1H)，3.39(s，1H)，2.11(s，36H)； 31P?NMR(121MHz，CDCl 3)：δ43.67ppm。
Embodiment 4: catalyzer 9
Productive rate: 80%.
1H?NMR(300MHz，CDCl 3)：δ7.41-7.35(m，12H)，7.16-7.11(m，18H)，6.87-6.84(m，4H)，4.28(t，J＝4.8Hz，2H)，3.61(m，2H)，3.35(s，1H)，3.32(s，1H)； 31P?NMR(121MHz，CDCl 3)：δ44.54ppm。
Embodiment 5: catalyzer 10
Employing method one, the first step are solvent refluxing 15 hours with ethanol, productive rate: 79%.
1H?NMR(300MHz，CDCl 3)：δ7.44-7.39(m，12H)，7.09-7.07(m，6H)，6.90-6.87(m，4H)，6.64(d，J＝5.4Hz，12H)，4.29(t，J＝4.8Hz，2H)，3.74-3.65(m，20H)； 31P?NMR(121MHz，CDCl 3)：δ41.65ppm。
Embodiment 6: catalyzer 11
Productive rate: 62%.
1H?NMR(300MHz，CDCl 3)：δ7.55-7.50(m，12H)，7.20-7.17(m，10H)，7.11-7.06(m，14H)，6.63(d，J＝5.4Hz，2H)，4.67(s，4H)，3.72(s，6H)，3.18(br，2H)； 31P?NMR(121MHz，CDCl 3)：δ44.98ppm。
Embodiment 7: catalyzer 12
Productive rate: 66%.
1H?NMR(300MHz，CDCl 3)：δ7.16-7.13(m，12H)，6.80(s，6H)，6.72(s，2H)，6.48(s，4H)，4.22(t，J＝4.5Hz，2H)，3.56(m，2H)，3.34(s，1H)，3.31(s，1H)，2.13(s，12H)，2.05(s，36H)； 31P?NMR(121MHz，CDCl 3)：δ43.71ppm。
Embodiment 8: catalyzer 13
Employing method one, the first step are solvent refluxing 12 hours with ethanol, and second step, the 2-ethylene dichloride was a solvent, reacted 10 hours with 1.Productive rate: 66%.
1H?NMR(300MHz，CDCl 3)：δ7.52-7.49(m，4H)，7.16-7.05(m，20H)，6.89-6.83(m，8H)，4.35(t，J＝4.5Hz，2H)，3.74-3.69(m，2H)，3.46(s，1H)，3.42，(s，1H)，2.32s，6H)，2.07(s，12H)，2.05(s，12H)； 31P?NMR(121MHz，CDCl 3)：δ43.95ppm。
Embodiment 9: catalyzer 14
Productive rate: 77%.
1H?NMR(300MHz，CDCl 3)：δ7.20-7.17(m，12H)，6.79(s，10H)，6.23(d，J＝7.2Hz，4H)，4.23(t，J＝4.5Hz，2H)，3.70(s，6H)，3.61(m，2H)，3.33，(s，1H)，3.31(s，1H)，2.04(s，36H)； 31P?NMR(121MHz，CDCl 3)：δ43.65ppm。
Embodiment 10: catalyzer 15
Employing method one, the first step refluxed 4 hours, and second step is intact with three chloromethanes to be solution, productive rate: 76%.
31P?NMR(121MHz，CDCl 3)：δ49.93ppm； 19F?NMR(282MHz，CDCl 3)：δ-63.55ppm。
Embodiment 11: catalyzer 16 (Ph 3P) 2RuCl 2[(S)-BINAM]
BINAM is: 2, and 2 '-dinaphthalene amine
Productive rate: 79%.
1H?NMR(300MHz，CDCl 3)：δ7.80(d，J＝8.1Hz，2H)，7.32(d，J＝8.7Hz，2H)，7.58(t，J＝8.4Hz，12H)，7.33-7.27(m，2H)，7.24-7.22(m，6H)，7.15-7.09(m，14H)，6.95(d，J＝8.4Hz，2H)，6.59(d，J＝8.7Hz，2H)，5.24(br，2H)，4.58(br，2H)； 31P?NMR(121MHz，CDCl 3)：δ47.25ppm。
Embodiment 12: catalyzer 17
Productive rate: 76%.
1H?NMR(300MHz，CDCl 3)：δ7.30-7.26(m，6H)，7.78-7.76(m，14H)，6.81(s，4H)，6.73(s，2H)，4.27(t，J＝4.2Hz，2H)，3.17(m，2H)，3.39(s，1H)，3.37，(s，1H)，2.20(s，12H)，2.05(s，36H)； 31P?NMR(121MHz，CDCl 3)：δ43.68ppm。
Embodiment 13: catalyzer 18 (Ph 3P) 2RuCl 2[(S, S)-m-CH 3-DPEN]
Productive rate: 70%.
1H?NMR(300MHz，CDCl 3)：δ7.52-7.50(m，14H)，7.23-7.19(m，16H)，6.96-6.91(m，4H)，6.66-6.60(m，4H)，4.23(t，J＝5.4Hz，2H)，3.68(m，2H)，3.32(s，1H)，3.30(s，1H)，2.18(s，6H)； 31P?NMR(121MHz，CDCl 3)：δ45.03ppm。
Embodiment 14: catalyzer 19 (Ph 3P) 2RuCl 2[(R, R)-p-OCH 3-DPEN]
Productive rate: 73%.
1H?NMR(300MHz，CDCl 3)：δ7.53-7.50(m，10H)，7.35-7.33(m，10H)，7.19-7.07(m，10H)，6.76(d，J＝8.7Hz，4H)，6.60(d，J＝8.7Hz，4H)，4.19(t，J＝4.5Hz，2H)，3.72(s，6H)，3.61(br，2H)，3.31(s，1H)，3.28(s，1H)； 31P?NMR(121MHz，CDCl 3)：δ44.98ppm。
Embodiment 15: catalyzer 20 (Ph 3P) 2RuCl 2[(S, S)-p-CH 3-DPEN]
Productive rate: 80%.
1H?NMR(300MHz，CDCl 3)：δ7.52-7.47(m，10H)，7.23-7.18(m，6H)，7.09(t，J＝7.5Hz，12H)，6.87(d，J＝8.1Hz，4H)，6.72(d，J＝7.8Hz，4H)，4.23(t，J＝4.5Hz，2H)，3.66(br，2H)，3.33(s，1H)，3.30(s，1H)，2.18(s，6H)； 31P?NMR(121MHz，CDCl 3)：δ44.97ppm。
Embodiment 16: catalyzer 21
Productive rate: 71%.
31P?NMR(121MHz，CDCl 3)：δ46.58ppm。
Embodiment 17: catalyzer 22 (Ph 3P) 2RuCl 2[(S, S)-3,5-Di-CH 3-DPEN]
Productive rate: 73%.
31P?NMR(121MHz，CDCl 3)：δ45.10ppm。
Embodiment 18: catalyzer 23
(Ph 3P) 2RuCl 2[(S)-DAIPEN]
Employing method one, the first step reaction is a solvent with the Virahol, refluxes 7 hours.Productive rate: 67%.
31P?NMR(121MHz，CDCl 3)：δ45.56ppm。
Method two
Figure A20051002363200141
Embodiment 19: the preparation of catalyzer 24
Universal method (method two): under argon shield with 128mg (0.202mmol) biphosphine ligand (or monophosphorus ligand 0.404mmol) and 50mg (0.10mol) [RuCl 2(C 6H 6)] 2Put into reaction tubes.Add the anhydrous N of 2mL, dinethylformamide (DMF) is put into 100 ℃ oil bath, stirs 30 minutes.Reduce to and add 46mg (0.216mmol) after the room temperature (R, R)-DPEN, stirring is spent the night.Reduce pressure then and DMF is taken out (can suitably heat, but temperature being no more than 50 ℃).The anhydrous CH of remaining solid 2Cl 2And the Hexane recrystallization can get red-brown solid 162mg.Productive rate: 84%.
31P?NMR(121MHz，CDCl 3)：δ47.87ppm。
Embodiment 20: catalyzer 25
Adopt N, dinethylformamide is a solvent, and 100 ℃ were reacted 1 hour.Productive rate: 84%.
31P?NMR(121MHz，CDCl 3)：δ47.78，47.59，47.29，47.09ppm。
Embodiment 21: catalyzer 26
Productive rate: 75%.
31P?NMR(121MHz，CDCl 3)：δ47.34ppm。
Embodiment 22: catalyzer 27
Adopt N, dinethylformamide is a solvent, and 100 ℃ were reacted 2 hours.Productive rate: 86%.
M.p.183-185℃；[α] 20 D＝+53.1°(c＝0.91，CHCl 3)；IR(KBr)ν3315cm -1(N-H)； 1HNMR(300MHz，CDCl 3)：δ8.09-8.06(m，12H)，7.42(s，6H)，7.31-7.25(m，26H)，7.19-7.12(m，34H)，7.03(t，J＝7.2Hz，2H)，6.92(t，J＝7.5Hz，4H)，6.79(d，J＝7.5Hz，4H)，4.45(m，2H)，4.12-4.15(m，2H)，3.67(br，2H)； 31P?NMR(121MHz，CDCl 3)：δ50.95ppm。
Embodiment 23: catalyzer 28
Adopt N, dinethylformamide is a solvent, and 100 ℃ were reacted 3 hours.Productive rate: 81%.
M.p.177-179℃；[α] 20 D＝+57.4°(c＝1.07，CHCl 3)；IR(KBr)ν3313cm -1(N-H)； 1HNMR(300MHz，CDCl 3)：δ8.07-7.98(m，12H)，7.37(s，6H)，7.02-6.84(m，32H)，6.76(s，16H)，4.43(br，2H)，4.01-3.97(m，2H)，3.61(br，2H)，2.11(s，36H)； 31P?NMR(121MHz，CDCl 3)：δ51.12ppm。
Embodiment 24: catalyzer 29 (Ph 3P) 2RuCl 2
Productive rate: 87%.
31P?NMR(121MHz，CDCl 3)：δ27.80ppm.
Embodiment 25: catalyzer 30 (Ph 3P) 2RuCl 2[(R)-NH 2(CH 3) CHPh] 2
Productive rate: 88%.
31P?NMR(121MHz，CDCl 3)：δ37.83ppm。
Embodiment 26: catalyzer 31
Productive rate: 73%.
31P?NMR(121MHz，CDCl 3)：δ43.79ppm。
Embodiment 27: catalyzer 32
Productive rate: 72%.
31P?NMR(121MHz，CDCl 3)：δ44.13ppm。
Embodiment 28: catalyzer 33
Productive rate: 84%.
31P?NMR(121MHz，CDCl 3)：δ43.45ppm。
Embodiment 29: catalyzer 34
Productive rate: 82%.
31P?NMR(121MHz，CDCl 3)：δ44.47ppm。
Embodiment 30: catalyzer 35
Productive rate: 80%.
31P?NMR(121MHz，CDCl 3)：δ28.52ppm。
Embodiment 31: catalyzer 36
Productive rate: 79%.
31P?NMR(121MHz，CDCl 3)：δ36.93ppm。
Embodiment 32: catalyzer 37[(S)-BINAP] RuCl 2(NH 2CH 2CH 2NH 2)
Productive rate: 87%.
31P?NMR(121MHz，CDCl 3)：δ45.93ppm。
Embodiment 33: catalyzer 38 (Ph 3P) 2RuCl 2[(R, R)-TsDPEN]
N-p-toluenesulfonyl-1, the 2-diphenyl ethylene diamine
Productive rate: 85%.
31P?NMR(121MHz，CDCl 3)：δ27.20ppm。
Embodiment 34: catalyzer 39
Productive rate: 77%.
31P?NMR(121MHz，CDCl 3)：δ27.84ppm。
Embodiment 35: catalyzer 40
Productive rate: 79%.
31P?NMR(121MHz，CDCl 3)：δ45.11ppm。
Embodiment 36: catalyzer 41
The employing N,N-dimethylacetamide is a solvent, and 100 ℃ were reacted 1 hour.Productive rate: 85%.
31P?NMR(121MHz，CDCl 3)：δ173.9ppm。
Embodiment 37: catalyzer 42
The employing N,N-dimethylacetamide is a solvent, and 100 ℃ were reacted 1 hour.Productive rate: 86%.
31P?NMR(121MHz，CDCl 3)：δ173.6ppm。
Embodiment 38: catalyzer 43
DACH is 1, the 2-cyclohexanediamine, and the employing N,N-dimethylacetamide is a solvent, 4 hours productive rates of 100 ℃ of reactions: 87%.
31P?NMR(121MHz，CDCl 3)：δ31.02ppm。
Embodiment 39: catalyzer 44 (Ph 3P) 2RuCl 2[(R, R)-DACH]
Productive rate: 87%.
31P?NMR(121MHz，CDCl 3)：δ44.82ppm。
Embodiment 40: catalyzer 45 (Ph 3P) 2PdCl 2[(R, R)-DPEN]
Under argon shield with 106mg (0.404mmol) PPh 3And 35mg (0.20mol) PdCl 2Put into reaction tubes.Add the 2mL dry toluene, put into 110 ℃ oil bath, stirred 5 hours.Reduce to and add 45mg (0.21mmol) after the room temperature (R, R)-DPEN, stirring is spent the night.Reduce pressure then and toluene is taken out (can suitably heat, but temperature being no more than 50 ℃).The anhydrous CH of remaining solid 2Cl 2And the Hexane recrystallization can get yellow solid 155mg.Productive rate: 85%.
31P?NMR(121MHz，CDCl 3)：δ22.40ppm。
Embodiment 41: catalyzer 46 (Ph 3P) 2CuCl 2[(S, S)-DPEN]
Under argon shield with 106mg (0.404mmol) PPh 3And 34mg (0.20mol) CuCl 22H 2O puts into reaction tubes.Add 2mL anhydrous dimethyl benzene, put into 110 ℃ oil bath, stirring reaction 7 hours.Reduce to and add 45mg (0.21mmol) after the room temperature (R, R)-DPEN, stirring is spent the night.Reduce pressure then and dimethylbenzene is taken out (can suitably heat, but temperature being no more than 50 ℃).The anhydrous CH of remaining solid 2Cl 2And the Hexane recrystallization can get green solid 145mg.Productive rate: 83%.
31P?NMR(121MHz，CDCl 3)：δ36.47ppm。
Embodiment 42: catalyzer 47 (Ph 3P) 2FeCl 2[(S, S)-DPEN]
Under argon shield with 106mg (0.404mmol) PPh 3And 40mg (0.20mol) FeCl 22H 2O puts into reaction tubes.Add the 2mL anhydrous dimethyl sulfoxide, put into 100 ℃ oil bath, during stirring reaction 15.Reduce to and add 45mg (0.21mmol) after the room temperature (R, R)-DPEN, stirring is spent the night.Reduce pressure then and methyl-sulphoxide is taken out (can suitably heat, but temperature being no more than 70 ℃).The anhydrous CH of remaining solid 2Cl 2And the Hexane recrystallization can get red solid 130mg.Productive rate: 75%.
31P?NMR(121MHz，CDCl 3)：δ44.82ppm。
Embodiment 43: catalyzer 48
The employing N,N-dimethylacetamide is a solvent, and 100 ℃ were reacted 5 hours.Productive rate: 87%.
31P?NMR(121MHz，CDCl 3)：δ45.86ppm。
Embodiment 44: catalyzer 49
Productive rate: 85%.
31P?NMR(121MHz，CDCl 3)：δ43.78ppm。
Embodiment 45: catalyzer 50
Productive rate: 88%.
31P?NMR(121MHz，CDCl 3)：δ42.37ppm。
Embodiment 46: catalyzer 51
Productive rate: 83%.
31P?NMR(121MHz，CDCl 3)：δ43.46ppm。
Embodiment 47: catalyzer 52
The employing dimethyl sulfoxide (DMSO) is a solvent, and 100 ℃ were reacted 5 hours.Productive rate: 79%.
31P?NMR(121MHz，CDCl 3)：δ44.69ppm。
Catalytic hydrogenation
Embodiment 48: the asymmetric hydrogenation of phenyl ethyl ketone (I):
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 240mg (2.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20 normal atmosphere (atm) pressure stirred under the room temperature after 5 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.5%.[α] D 20=-53.7 ° of (c=0.87, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (SuplcoBETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 49: the asymmetric hydrogenation of phenyl ethyl ketone (II):
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 2.40g (20mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.1%; [α] 20 D=-53.6 ° of (c=0.90, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (SuplcoBETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; T (R), 14.7min; T (S), 15.2min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 50: the asymmetric hydrogenation of phenyl ethyl ketone (III):
Under argon shield, in the reaction tubes of an existing magneton, add 2.7mg (0.003mmol) catalyzer 6 and 6.7mg (0.06mmol) t-BuOK, the 2.0mL anhydrous isopropyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 6 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 75.5%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the S configuration.
Embodiment 51: the asymmetric hydrogenation of phenyl ethyl ketone (IV):
Under argon shield, in the reaction tubes of an existing magneton, add 3.2mg (0.003mmol) catalyzer 8 and 6.7mg (0.06mmol) t-BuOK, the 2.0mL anhydrous isopropyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 10atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 87.0%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the S configuration.
Embodiment 52: the asymmetric hydrogenation of phenyl ethyl ketone (V):
Under argon shield, in the reaction tubes of an existing magneton, add 3.5mg (0.003mmol) catalyzer 15 and 5.7mg (0.06mmol) t-BuONa, the 2.0mL anhydrous isopropyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 8 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 77.1%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the S configuration.
Embodiment 53: the asymmetric hydrogenation of phenyl ethyl ketone (VI):
Under argon shield, in the reaction tubes of an existing magneton, add 3.0mg (0.003mmol) catalyzer 25 and 3.3mg (0.06mmol) KOH, the 3.0mL anhydrous isopropyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 81.5%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the S configuration.
Embodiment 54: the asymmetric hydrogenation of phenyl ethyl ketone (VII):
Under argon shield, in the reaction tubes of an existing magneton, add 3.9mg (0.005mmol) catalyzer 49 and 4.0mg (0.10mmol) NaOH, the anhydrous n-propyl alcohol of 5.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 12 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 75.5%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the S configuration.
Embodiment 55: the asymmetric hydrogenation of phenyl ethyl ketone (VIII):
Under argon shield, in the reaction tubes of an existing magneton, add 4.1mg (0.005mmol) catalyzer 48 and 4.0mg (0.10mmol) NaOH, the anhydrous n-propyl alcohol of 5.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 360mg (3.0mmol) phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 40atm pressure stirred under the room temperature after 16 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get the 1-phenylethyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 75.5%. 1H NMR (300MHz, CDCl 3) δ 7.34-7.32 (m, 5H), 4.82 (q, J=9.6Hz, 1H), 2.61 (br, 1H), 1.44 (d, J=4.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 120 ℃; Retention time t (R), 14.7min; T (S), 15.2min, absolute configuration is the R configuration.
The asymmetric hydrogenation of embodiment 56:4 '-aminomethyl phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 30 minutes after, add 268mg (2.0mmol) 4 '-aminomethyl phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 4 '-aminomethyl phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 93.7%, [α] D 20=-52.1 ° of (c=0.89, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.28 (d, J=7.8Hz, 2H), 7.18 (d, J=7.8Hz, 2H), 4.87 (q, J=9.6Hz, 1H), 2.35 (s, 3H), 1.88 (br, 1H), 1.50 (d, J=6.3Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 135 ℃; T (R), 11.7min; T (S), 12.2min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 57:2 '-aminomethyl phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 268mg (2.0mmol) 2 '-aminomethyl phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 7 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-aminomethyl phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.1%; [α] D 20=-72.5 ° of (c=0.75, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.50 (d, J=7.8Hz, 1H), 7.24-7.29 (m, 3H), 5.09 (q, J=6.3Hz, 1H), 2.32 (s, 3H), 2.11 (br, 1H), 1.44 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mmi.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 135 ℃; T (R), 14.2min; T (S), 15.8min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 58:2 '-p-methoxy-phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 300mg (2.0mmol) 2 '-p-methoxy-phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-p-methoxy-phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 93.3%; [α] D 20=-23.4 ° of (c=0.79, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.36-7.33 (m, 1H), 7.28-7.22 (m, 1H), 6.99 (t, J=7.2Hz, 1H), 6.87 (d, J=8.1Hz, 1H), 5.12 (q, J=6.0Hz, 1H), 3.89 (s, 3H), 1.52 (d, J=6.1Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 135 ℃; T (S), 17.6min; T (R), 18.7min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 59:4 '-p-methoxy-phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 268mg (2.0mmol) 4 '-p-methoxy-phenyl ethyl ketone again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 40atm pressure stirred under the room temperature after 2 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 4 '-p-methoxy-phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 87.9%.[α] D 20=-44.6 ° of (c=0.85, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.31 (d, J=9.0Hz, 2H), 6.89 (d, J=9.0Hz, 2H), 4.87 (q, J=6.3Hz, 1H), 3.78 (s, 3H), 1.99 (br, 1H), 2.11 (br, 1H), 1.44 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 0.8mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 140 ℃; T (R), 27.0min; T (S), 27.8min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 60:2 '-bromo phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 400mg (2.0mmol) 2 '-bromo phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-bromo phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 96.1%.[α] D 20=-52.1 ° of (c=0.93, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.61 (d, J=8.1Hz, 1H), 7.52 (d, J=8.1Hz, 1H), 7.34 (t, J=15.3Hz, 1H), 7.13 (t, J=15.0Hz, 1H), 5.24 (q, J=9.6Hz, 1H), 1.49 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 140 ℃; T (R), 13.0min; T (S), 14.9min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 61:3 '-bromo phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 400mg (2.0mmol) 3 '-bromo phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 4 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 3 '-bromo phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 93.3%; [α] D 20=-29.3 ° of (c=0.96, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.52 (s, 1H), 7.41-7.37 (m, 1H), 7.29-7.17 (m, 2H), 4.87 (q, J=6.3Hz, 1H), 2.20 (br, 1H), 1.50 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mmi.d.x 30m); Carrier gas is N 2(flow velocity is 1.1mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 150 ℃; T (R), 18.9min; T (S), 19.3min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 62:4 '-bromo phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 400mg (2.0mmol) 4 '-bromo phenyl ethyl ketone again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 3 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 4 '-bromo phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 80.5%; [α] D 20=-25.2 ° (c=0.83, CHOH); 1H NMR (300MHz, CDCl 3) δ 7.49 (d, J=9.0Hz, 2H), 7.46 (d, J=9.0Hz, 2H), 4.90 (q, J=6.6Hz, 1H), 1.88 (br, 1H), 1.48 (d, J=6.3Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.1mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 155 ℃; T (R), 16.4min; T (S), 17.1min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 63:2 '-chlorophenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the 2.0mL anhydrous normal butyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 310mg (2.0mmol) 2 '-chlorophenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-chlorophenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 96.3%; [α] D 20=-60.3 ° of (c=0.80, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.59 (d, J=7.8Hz, 1H), 7.33-7.22 (m, 2H), 7.21-7.17 (m, 1H), 5.29 (q, J=6.3Hz, 1H), 2.20 (br, 1H), 1.50 (d, J=4.5Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 155 ℃; T (R), 8.4min; T (S), 9.2min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 64:3 '-chlorophenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 30 minutes after, add 310mg (2.0mmol) 3 '-chlorophenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 40atm pressure stirred under the room temperature after 13 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 3 '-chlorophenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.3%; [α] D 20=-40.0 ° of (c=0.60, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.36 (s, 1H), 7.29-7.19 (m, 3H), 4.87 (q, J=6.6Hz, 1H), 1.47 (d, J=8.1Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 140 ℃; T (R), 17.0min; T (S), 17.5min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 65:4 '-chlorophenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 310mg (2.0mmol) 4 '-chlorophenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 4 '-chlorophenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 84.7%; [α] D 20=-28.2 ° of (c=0.75, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.31 (m, 4H), 4.88 (q, J=6.6Hz, 1H), 1.48 (d, J=5.7Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 145 ℃; T (R), 14.6min; T (S), 15.3min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 66:2 '-fluoro phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 278mg (2.0mmol) 2 '-fluoro phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 20 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-fluoro phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.1%; [α] D 20=-38.2 ° of (c=0.92, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.51-7.45 (m, 1H), 7.28-7.19 (m, 1H), 7.17-7.11 (m, 1H), 7.04-6.98 (m, 1H), 4.87 (q, J=6.3Hz, 1H), 2.36 (br, 1H), 1.53 (d, J=6.0Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 125 ℃; T (R), 12.1min; T (S), 12.8min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 67:4 '-fluoro phenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 280mg (2.0mmol) 4 '-fluoro phenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 4 '-fluoro phenyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 91.5%; [α] D 20=-42.5 ° of (c=0.91, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.33-7.26 (m, 2H), 7.05-6.97 (m, 2H), 4.88 (q, J=6.3Hz, 1H), 2.32 (br, 1H), 1.46 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.1mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 125 ℃; T (R), 12.7min; T (S), 13.4min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 68:2 '-trifluoromethyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 378mg (2.0mmol) 2 '-trifluoromethyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 9 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-trifluoromethyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 96.5%; [α] D 20=-43.4 ° of (c=0.74, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.82 (d, J=7.8Hz, 1H), 7.61-7.55 (m, 2H), 7.38-7.33 (m, 1H), 5.34 (q, J=6.0Hz, 1H), 2.25 (br, 1H), 1.47 (d, J=6.3Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 130 ℃; T (R), 8.7min; T (S), 9.5min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 69:3 ', the asymmetric hydrogenation of 5 '-two trifluoromethyl ethyl ketones:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 515mg (2.0mmol) 3 ', 5 '-two trifluoromethyl ethyl ketones with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 3 ', 5 '-two trifluoromethyls-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 90.9%; [α] D 20=-20.0 ° of (c=0.79, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.84 (s, 2H), 7.79 (s, 1H), 5.06 (q, J=3.0Hz, 1H), 2.00 (br, 1H), 1.56 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 125 ℃; T (S), 7.0min; T (R), 7.6min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 70:1 '-naphthyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, 2.0mL anhydrous normal butyl alcohol and 5 μ L Et are injected in gas argon replaces three times in the bottle 3N.Stir made solid dissolving in 20 minutes after, add 340mg (2.0mmol) 1 '-naphthyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 15 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 1 '-naphthyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 94.7%; [α] D 20=-57.4 ° of (c=0.86, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 8.11-8.08 (m, 1H), 7.89-7.86 (m, 1H), 7.79 (d, J=8.1Hz, 1H), 7.68 (d, J=6.9Hz, 1H), 7.55-7.45 (m, 3H), 7.38-7.33 (m, 1H), 5.68 (q, J=6.6Hz, 1H), 2.18 (br, 1H), 1.66 (d, J=7.2Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 175 ℃; T (S), 23.2min; T (R), 24.0min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 71:2 '-naphthyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, 2.0mL anhydrous normal butyl alcohol E and 5 μ L Et are injected in gas argon replaces three times in the bottle 3N.Stir made solid dissolving in 20 minutes after, add 340mg (2.0mmol) 2 '-naphthyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-naphthyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 90.5%; [α] D 20=-47.2 ° of (c=0.82, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.86-7.83 (m, 4H), 7.53-7.46 (m, 3H), 3.51 (q, J=7.0Hz, 1H), 1.61 (d, J=6.0Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 170 ℃; T (R), 32.2min; T (S), 32.7min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 72: the asymmetric hydrogenation of ferrocenyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, 2.0mL anhydrous normal butyl alcohol and 5 μ L Et are injected in gas argon replaces three times in the bottle 3N.Stir made solid dissolving in 20 minutes after, add 460mg (2.0mmol) ferrocenyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get ferrocenyl-1-ethanol.Through liquid-phase chromatographic analysis, the enantiomeric excess of product is 87.5%; [α] D 20=+26.1 ° of (c=0.77, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 4.58 (q, J=6.0Hz, 1H), 4.21-4.18 (m, 9H), 1.46 (d, J=6.6Hz, 3H); High performance liquid chromatography (the Chiralpak Japan AS-H of DaCheng Co., Ltd chiral column, λ=254nm; Flow velocity: 0.7mL/min, normal hexane: Virahol=95: 5; T (S)=16.9min; T (R)=24.4min); The product absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 73:2 '-furyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 220mg (2.0mmol) 2 '-furyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 4 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-furyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 89.5%; [α] D 20=-9.1 ° of (c=1.56, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.38-7.37 (m, 1H), 6.34-6.32 (m, 1H), 6.24-6.23 (m, 1H), 4.90 (q, J=6.3Hz, 1H), 1.56 (d, J=6.3Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 95 ℃; T (R), 13.2min; T (S), 13.5min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 74:2 '-thienyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 255mg (2.0mmol) 2 '-thienyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-thienyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.9%; [α] D 20=-29.1 ° of (c=0.74, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.29-7.26 (m, 1H), 7.02-6.98 (m, 2H), 5.18 (q, J=6.3Hz, 1H), 2.36 (br, 1H), 1.63 (d, J=6.3Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.2mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 115 ℃; T (R), 18.3min; T (S), 19.1min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 75:2 '-pyridyl ethyl ketone:
Under argon shield; in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK; 4.6 μ L (0.02mmol) triisopropyl boric acid esters and the anhydrous n-propyl alcohol of 2.0mL are injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 244mg (2.0mmol) 2 '-pyridyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 8 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 2 '-pyridyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 80.7%; [α] D 20=-47.4 ° (c=0.78, EtOH); 1H NMR (300MHz, CDCl 3) δ 8.54 (d, J=5.1Hz, 1H), 7.72-7.64 (m, 1H), 7.30 (d, J=7.8Hz, 1H), 7.21 (m, 1H), 4.89 (q, J=6.6Hz, 1H), 1.52 (d, J=6.6Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.1mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 105 ℃; T (R), 23.1min; T (S), 23.5min, absolute configuration is by measuring [α] DBe the S configuration.
The asymmetric hydrogenation of embodiment 76:3 '-pyridyl ethyl ketone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the 2.0mL anhydrous normal butyl alcohol is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 244mg (2.0mmol) 3 '-pyridyl ethyl ketone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get 3 '-pyridyl-1-ethanol.Through gas chromatographic analysis, the enantiomeric excess of product is 95.5%; [α] D 20=-42.9 ° (c=0.76, EtOH); 1H NMR (300MHz, CDCl 3) δ 8.53 (s, 1H), 8.46-8.44 (m, 1H), 7.76-7.72 (m, 1H), 7.30-7.26 (m, 1H), 4.95 (q, J=6.6Hz, 1H), 2.00 (br, 1H), 1.52 (d, J=6.9Hz, 3H); Gas-chromatography (Suplco BETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 140 ℃; T (R), 15.1min; T (S), 15.5min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 77: the asymmetric hydrogenation of phenyl-acetone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 268mg (2.0mmol) phenyl-acetone with syringe again, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 20atm pressure stirred under the room temperature after 5 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get phenyl-1-propyl alcohol.Through gas chromatographic analysis, the enantiomeric excess of product is 96.3%; [α] D 20=-46.0 ° of (c=1.00, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.35-7.28 (m, 5H), 4.58 (t, J=6.0Hz, 1H), 1.82-1.74 (m, 2H), 0.91 (t, J=7.5Hz, 3H); Gas-chromatography (SuplcoBETA-DEX TM120, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.0mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 125 ℃; T (S), 18.5min; T (R), 19.0min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 78: γ-N, and the asymmetric hydrogenation of N-dimethylamino-α-Propiophenone:
Under argon shield, in the reaction tubes of an existing magneton, add 4.3mg (0.002mmol) catalyzer 28 and 4.5mg (0.04mmol) t-BuOK, the anhydrous n-propyl alcohol of 2.0mL is injected in gas argon replaces three times in the bottle.Stir made solid dissolving in 20 minutes after, add 356mg (2.0mmol) γ-N with syringe again, N-dimethylamino-α-Propiophenone, and seal with soft rubber ball.In with the glove box of nitrogen protection, the soft rubber ball on the reaction flask is opened; and reaction flask is transferred in the autoclave; after sealing, shifts out by autoclave glove box; with high-purity hydrogen with the careful displacement of the nitrogen in the autoclave four times after; the hydrogen that adds 30atm pressure stirred under the room temperature after 10 hours, after the hydrogen in the autoclave is bled off; after the removal of solvent under reduced pressure, be greater than 99% with the magnetic resonance detection feed stock conversion.The liquid remaining reaction filters with the long silicagel column of 10cm, and developping agent is an ethyl acetate: sherwood oil 10: 1 can get γ-N, N-dimethylamino-α-phenylpropyl alcohol.Through liquid-phase chromatographic analysis, the enantiomeric excess of product is 96.7%; [α] D 20=-21.0 ° of (c=0.91, CHCl 3); 1H NMR (300MHz, CDCl 3) δ 7.40-7.24 (m, 5H), 4.96 (q, J=4.5Hz, 1H), 2.66-2.62 (m, 1H), 2.51-2.45 (m, 1H), 2.31 (s, 6H), 1.86-1.81 (m, 2H); High performance liquid chromatography (the Chiralcel Japan OD-H of DaCheng Co., Ltd chiral column, λ=254nm; Flow velocity: 1.0mL/min, normal hexane: Virahol=95: 5; T (R)=4.5min; T (S)=6.2min); The product absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 79: the asymmetric hydrogenation of cyclopropyl ethyl ketone:
Under argon shield; in the 300mL autoclave body of an existing magneton, add 3.5mg (0.0035mmol) catalyzer 6 and 35mg (0.625mmol) NaOH; gas argon replaces three times in the bottle; after injecting the 5.0mL anhydrous methanol, add 29.5g (350mmol) cyclopropyl ethyl ketone with syringe again.After autoclave sealed, with high-purity hydrogen with the careful displacement of the argon gas in the autoclave four times after, add the hydrogen of 50atm pressure, stir under the room temperature after 24 hours, after the hydrogen in the autoclave is bled off, be greater than 99% with the magnetic resonance detection feed stock conversion.After the reactant distillation, can get cyclopropyl-1-ethanol 28 grams, yield: 95%.Enantiomeric excess through the gas chromatographic analysis product is 30.3%.[α] D 20=-7.0 ° of (c=1.00, CHCl 3); 1H NMR (300MHz, CDCl 3): δ 3.17-3.04 (m, 1H), 1.29 (d, J=6.3Hz, 3H), 0.94-0.88 (m, 1H), 0.53-0.49 (m, 2H), 0.35-0.31 (m, 1H), 0.22-0.17 (m, 1H); Gas-chromatography (Suplco BETA-DEX TM325, df=0.25 μ m, 0.25mm i.d.x 30m); Carrier gas is N 2(flow velocity is 1.3mL/min); Injector temperature is 250 ℃; Detector temperature is 300 ℃; Column temperature is 50 ℃; T (S), 12.5min; T (R), 12.9min, absolute configuration is by measuring [α] DBe the S configuration.
Embodiment 80: the hydrogenation of diphenylmethanone:
Under argon shield; in the 300mL autoclave body of an existing magneton, add 5mg (0.0055mmol) catalyzer 6 and 91mg (1.63mmol) KOH and 100g (550mmol) diphenylmethanone; gas injects the 180mL anhydrous isopropyl alcohol with after the argon replaces three times in the bottle.After autoclave sealed, with high-purity hydrogen with the careful displacement of the argon gas in the autoclave four times after, add the hydrogen of 70atm pressure, stir under the room temperature after 24 hours, after the hydrogen in the autoclave is bled off, be greater than 99% with the magnetic resonance detection feed stock conversion.After solvent removed, can get diphenyl-carbinol 94 grams, yield: 94%. 1H?NMR(300MHz，CDCl 3)：δ7.36-7.32(m，10H)，5.80(s，1H)
Embodiment 81:4, the hydrogenation of 4 '-difluorodiphenyl base ketone:
Under argon shield; in the 1L autoclave body of an existing magneton, add 8.3mg (0.009mmol) catalyzer 6 and 410mg (3.65mmol) t-BuOK and 100g (458mmol) 4; 4 '-difluorodiphenyl base ketone; gas is with after the argon replaces three times in the bottle; inject the 450mL anhydrous isopropyl alcohol.After autoclave sealed, with high-purity hydrogen with the careful displacement of the argon gas in the autoclave four times after, add the hydrogen of 80atm pressure, stir under the room temperature after 24 hours, after the hydrogen in the autoclave is bled off, be greater than 99% with the magnetic resonance detection feed stock conversion.After solvent removed, underpressure distillation can get 4,4 '-difluorodiphenyl base methyl alcohol, 90 grams, yield: 90%. 1H?NMR(300MHz，CDCl 3)：δ7.33-7.29(m，4H)，7.05-7.00(m，4H)，5.79(s，1H)。
Explanation to above-mentioned asymmetric hydrogenation:
Employed solvent can be methyl alcohol, ethanol, Virahol, n-propyl alcohol, propyl carbinol, isopropylcarbinol, positive alcohol, benzene,toluene,xylene, trimethylbenzene, acetonitrile, ether, tetrahydrofuran (THF), glycol dinitrate fan, chloroform, methylene dichloride, dimethyl sulfoxide (DMSO), N-Methyl pyrrolidone etc. in the above-mentioned asymmetric H-H reaction.
Used alkali can be sodium hydroxide, potassium hydroxide, carbonate, supercarbonate, phosphoric acid salt, hydrophosphate, dihydrogen phosphate, fluoride salt, sodium hydride, potassium hydride KH, hydrolith, triethylamine, diisopropyl ethyl amine, Tetramethyl Ethylene Diamine, N, accelerine, N, N-Diethyl Aniline, 1,4-diazabicylo [2,2,2] octane (DABCO), diazabicylo dodecane (DBU), 1,4-lupetazin, 1-methyl piperidine, 1-methylpyrrole, quinoline or pyridine etc.
Adopt the pressure of hydrogen can be 5-80atm, the reaction times can be 2-48 hour.

Claims (9)

1. a metal Ru complex compound and other transition metal complex have following structural formula:
Figure A2005100236320002C1
Wherein A or B are R 1R 2R 3P, perhaps A and B are
Figure A2005100236320002C2
D or E=R 7Or R 8, perhaps D and E=R 13, M is Ru, Pd, Cu or Fe; X is chlorine, bromine, iodine; R 9Be hydrogen, methyl sulphonyl or to the Methyl benzenesulfonyl base; Wherein, R 1, R 2, R 3, R 4, R 5Or R 6Be C 2-12Alkyl, R 14Or R 15Be hydrogen, methyl, ethyl, n-propyl, sec.-propyl, cyclopropyl, normal-butyl, the tertiary butyl, cyclopentyl, cyclohexyl, suberyl, methoxyl group, oxyethyl group, positive propoxy, isopropoxy, phenyl, phenoxy group, methylphenoxy, 3,5-3,5-dimethylphenyl, benzyl, 3,5-dimethyl benzyl and naphthyl, R 7Or R 8Be R 17Be methyl, ethyl, n-propyl, sec.-propyl, methoxyl group, oxyethyl group, positive propoxy or isopropoxy, the monoamine part is chirality monoamine part or is not the monoamine part of chirality that the absolute configuration of the monoamine part of chirality is R configuration or S configuration, R 13Be the following group:
Figure A2005100236320002C5
Or
Figure A2005100236320002C6
, R wherein 18Or R 19Be hydrogen, methyl, ethyl, n-propyl, sec.-propyl, methoxyl group, oxyethyl group, positive propoxy or isopropoxy, diamine ligand is chirality or is not the diamine ligand of chirality, the absolute configuration of the diamine ligand of property both can be (R, R) configuration, also can be (S, S) configuration, when adopting biphosphine ligand, R wherein 12Be the following group:
Figure A2005100236320003C1
Figure A2005100236320003C2
Or
R wherein 10Or R 11Be phenyl, p-methylphenyl or 3,5-3,5-dimethylphenyl.
2. a metal Ru complex compound and other transition metal complex is characterized in that having following structural formula:
Figure A2005100236320003C4
Or
Wherein M, X, R 1, R 2, R 3, R 7, R 8, R 9, R 10, R 11, R 12Or R 13According to claim 1.
3. a kind of metal Ru complex compound as claimed in claim 1 and other transition metal complex is characterized in that described C 2-12Alkyl be ethyl, n-propyl, sec.-propyl, cyclopropyl, normal-butyl, the tertiary butyl, cyclopentyl, cyclohexyl, suberyl, phenyl, benzyl, 3,5-dimethyl benzyl, 1-naphthyl, 2-naphthyl or
Figure A2005100236320003C7
4. the synthetic method of a kind of metal Ru complex compound as claimed in claim 1 and other transition metal complex, it is characterized in that in organic solvent neutralization reaction temperature be under 0 ℃-100 ℃, transistion metal compound, diamine ligand or monoamine part, biphosphine ligand or monophosphorus ligand reaction obtained in 0.5～20 hour, wherein the mol ratio of transistion metal compound, diamine ligand or monoamine part, biphosphine ligand or monophosphorus ligand is 1: 1～5: 1～5, the structural formula of described diamine ligand or monoamine part is A and B, and the structural formula of described biphosphine ligand or monophosphorus ligand is
Figure A2005100236320003C8
With Wherein A, B, E, D and R 9According to claim 1, described transistion metal compound is the halogenide of Ru, Pd, Cu or Fe or their complex compound.
5. the synthetic method of a kind of metal Ru complex compound as claimed in claim 3 and other transition metal complex, when it is characterized in that adopting monoamine or monophosphorus ligand, the mol ratio of transistion metal compound and monoamine or monophosphorus ligand is 1: 3～5.
6. the synthetic method of a kind of metal Ru complex compound as claimed in claim 3 and other transition metal complex, when it is characterized in that adopting diamine or biphosphine ligand, the mol ratio of transistion metal compound and diamine or biphosphine ligand is 1: 1～3.
7. the synthetic method of a kind of metal Ru complex compound as claimed in claim 3 and other transition metal complex is characterized in that described transistion metal compound is [RuX 2(C 6H 6)] 2, RuX 3, PdX 2, CuX 2Or FeX 2, described X is a halogen.
8. the purposes of a kind of metal Ru complex compound as claimed in claim 1 and other transition metal complex is characterized in that described transition metal complex is used for the catalysis asymmetric hydrogenation.
9. the purposes of a kind of metal Ru complex compound as claimed in claim 1 and other transition metal complex, it is characterized in that described transition metal complex is used for methyl phenyl ketone and derivative, benzophenone and derivative thereof, methyl cyclopropyl ketone, γ-N, the catalytic hydrogenation of N-dimethylamino-α-Propiophenone and derivative thereof and other ketone compounds.
CNB2005100236320A 2005-01-27 2005-01-27 Transition metal complex, synthesis and use thereof Expired - Fee Related CN1331874C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100236320A CN1331874C (en) 2005-01-27 2005-01-27 Transition metal complex, synthesis and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100236320A CN1331874C (en) 2005-01-27 2005-01-27 Transition metal complex, synthesis and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN 200710095929 Division CN101037451A (en) 2005-01-27 2005-01-27 Transition metal complex, synthesizing method and application in catalytic hydrogenation reaction

Publications (2)

Publication Number Publication Date
CN1680412A true CN1680412A (en) 2005-10-12
CN1331874C CN1331874C (en) 2007-08-15

Family

ID=35067212

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100236320A Expired - Fee Related CN1331874C (en) 2005-01-27 2005-01-27 Transition metal complex, synthesis and use thereof

Country Status (1)

Country Link
CN (1) CN1331874C (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009149670A1 (en) * 2008-06-13 2009-12-17 Enantiotech Corporation Limited Novel ruthenium complexes having hybrid amine ligands, their preparation and use
CN101940951A (en) * 2010-09-26 2011-01-12 温州大学 Load-type chiral catalyst and application thereof in catalysis preparation of Fluoxetine intermediate
CN102000606A (en) * 2010-10-12 2011-04-06 中国科学院兰州化学物理研究所 Chiral ruthenium catalyst and use thereof in asymmetric hydrogenation of ketone
CN102381990A (en) * 2010-08-31 2012-03-21 凯瑞斯德生化(苏州)有限公司 Preparation method of optically active N-benzyl phenylephrine
CN102417523A (en) * 2010-09-27 2012-04-18 中山奕安泰医药科技有限公司 Nitrogen heterocyclic ligand transition metal complex, preparation and catalytic application thereof
CN101323630B (en) * 2008-07-25 2013-06-05 中国科学院上海有机化学研究所 Transient metal complex compound, synthetic method and use thereof
WO2013120860A1 (en) 2012-02-15 2013-08-22 Syngenta Participations Ag Process for the stereoselective preparation of a pyrazole carboxamide
CN108080029A (en) * 2017-12-27 2018-05-29 商丘师范学院 A kind of preparation method and application of two core methylimidazole copper complex catalyst
CN109311790A (en) * 2016-06-10 2019-02-05 奇华顿股份有限公司 The method that alcohol is prepared by alpha, beta-unsaturated aldehyde and ketone

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102917339B (en) 2012-10-11 2014-06-11 华为技术有限公司 Methods, device and system for realization and communication of virtual subscriber identity module

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001002610A (en) * 1999-04-23 2001-01-09 Nippon Soda Co Ltd Production of optically active alcohol and transition metal complex

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009149670A1 (en) * 2008-06-13 2009-12-17 Enantiotech Corporation Limited Novel ruthenium complexes having hybrid amine ligands, their preparation and use
WO2009149611A1 (en) * 2008-06-13 2009-12-17 中国科学院上海有机化学研究所 A nitrogenous transition metal complex, synthesis and use thereof
CN101323630B (en) * 2008-07-25 2013-06-05 中国科学院上海有机化学研究所 Transient metal complex compound, synthetic method and use thereof
CN102381990A (en) * 2010-08-31 2012-03-21 凯瑞斯德生化(苏州)有限公司 Preparation method of optically active N-benzyl phenylephrine
CN101940951A (en) * 2010-09-26 2011-01-12 温州大学 Load-type chiral catalyst and application thereof in catalysis preparation of Fluoxetine intermediate
CN101940951B (en) * 2010-09-26 2012-06-20 温州大学 Load-type chiral catalyst and application thereof in catalysis preparation of Fluoxetine intermediate
CN102417523A (en) * 2010-09-27 2012-04-18 中山奕安泰医药科技有限公司 Nitrogen heterocyclic ligand transition metal complex, preparation and catalytic application thereof
CN102417523B (en) * 2010-09-27 2014-10-08 中山奕安泰医药科技有限公司 Nitrogen heterocycle ligand transition metal complex, and preparation and catalytic application thereof
CN102000606A (en) * 2010-10-12 2011-04-06 中国科学院兰州化学物理研究所 Chiral ruthenium catalyst and use thereof in asymmetric hydrogenation of ketone
WO2013120860A1 (en) 2012-02-15 2013-08-22 Syngenta Participations Ag Process for the stereoselective preparation of a pyrazole carboxamide
CN109311790A (en) * 2016-06-10 2019-02-05 奇华顿股份有限公司 The method that alcohol is prepared by alpha, beta-unsaturated aldehyde and ketone
CN108080029A (en) * 2017-12-27 2018-05-29 商丘师范学院 A kind of preparation method and application of two core methylimidazole copper complex catalyst

Also Published As

Publication number Publication date
CN1331874C (en) 2007-08-15

Similar Documents

Publication Publication Date Title
CN1680412A (en) Transition metal complex, synthesis and use thereof
CN1062273C (en) Metal compound containing heterocyclic carbene
CN1291996C (en) Ruthenium complexes as (pre)catalysts for metathesis reactions
CN1610688A (en) Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
CN1181083A (en) Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11] and related compounds
CN101328191A (en) Nitrogen-containing ligand transient metal complex compound , synthetic method and use thereof
CN1537088A (en) Transfer hydrogenation process and catalyst
CN1231433C (en) Transfer hydrogenation process
CN1608074A (en) P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
CN1974547A (en) Ionic liquid of alkyl guanidine salt and its prepn process
CN1835909A (en) Process for the preparation of aromatic amines
CN101037451A (en) Transition metal complex, synthesizing method and application in catalytic hydrogenation reaction
CN1898255A (en) Process for the preparation of pyridine derivatives
CN1839122A (en) Ioninc liquids based on imidazolium salts incorporating a nitrile functionality
CN1283645C (en) Novel strong acids, process for the preparation thereof, and uses thereof
CN88102150A (en) Method for producing ibuprofen
CN1545502A (en) Process for the preparation of indole derivatives
CN1907992A (en) Ruthenium complex compound ligand, ruthenium complex compound, solid carrying ruthenium complex catalyst and preparation method and use thereof
CN1946670A (en) Methods of preparing 1,3-enyne preparation using copper (I) catalysts
CN1874844A (en) Method for the production of nickel(0)-phosphorous ligand complexes
CN100344376C (en) Recyclable chiral metathesis catalysts
CN1737005A (en) Chiral diphosphor compound an transition metal complex thereof
CN1639171A (en) Process for production of heteroaryl-type boron compounds with iridium catalyst
CN101054355A (en) Compound of optically pure disulfenamides and application thereof
CN1218941C (en) Process for preparing ethyl-sulfonylpiperidine derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070815

Termination date: 20130127

CF01 Termination of patent right due to non-payment of annual fee